PrimeRFP SCOUT · Federal Contract Recompete Brief

75N91020F00026Development of TARGET characterization methods — Leidos Biomedical Research, Inc

Leidos Biomedical Research, Inc holds $2.1B across 186 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Recompete timing centers on the May 25, 2027 PoP end — agencies typically plan 12–18 months ahead.

Nih Nci

Awarding office

Leidos Biomedical Research, Inc

Recipient

May 25, 2027

PoP end

$15.5M

Obligated

541715

NAICS

AN12

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Leidos Biomedical Research, Inc — $90

Contract facts

Federal

Contract number75N91020F00026

Also listed as75N91019D00024-75N91020F00026

AgencyNih Nci

Awarding officeNih Nci

IncumbentLeidos Biomedical Research, Inc

UEIHV8BH9BPG8Y9

NAICS541715

PSCAN12

Parent IDIQ / IDV75N91019D00024

Place of performanceFREDERICK, MD

PoP end (current)May 25, 2027

Obligated$15.5M

DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS is a federal award for Nih Nci held by Leidos Biomedical Research, Inc. Estimated value $56.5M ($15.5M obligated). Current period of performance ends May 25, 2027. Place of performance: FREDERICK, MD.

DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS

Recompete timing

Public

● Expiring in 257 days

Current PoP ends May 25, 2027 (257 days remaining). Agencies typically plan 12–18 months ahead — at 8.4 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Leidos Biomedical Research, Inc — $2.1B obligated across 186 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$2.1B · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

75N91020F00009

ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$89.6M

Jul 31, 2028

75N91020F00025

DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT,…

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$97.5M

Sep 24, 2028

75N91019F00139

MD NET

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$163.5M

Sep 29, 2028

75N91020F00039

NIAID COVID-19 ACTIV3

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$281.6M

Sep 29, 2029

75N91020F00014

COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN…

Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.

$50.0M

Sep 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N91020F00026?

75N91020F00026 (Development of TARGET characterization methods) is a Nih Nci award with an estimated value of $56.5M, currently held by Leidos Biomedical Research, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N91020F00026?

Nih Nci awarded 75N91020F00026 to Leidos Biomedical Research, Inc.

Who is the incumbent on 75N91020F00026?

Leidos Biomedical Research, Inc is the incumbent with $2.1B across 186 related awards in SCOUT’s public footprint. The current period of performance ends May 25, 2027.

When does Leidos Biomedical Research, Inc’s 75N91020F00026 come up for recompete?

SCOUT tracks a period-of-performance end of May 25, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N91020F00026 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Sep 25, 2025